Internal Medicine Doctors in Stone Mountain, GA Accepting Medicare

9 Internal Medicine doctors found. Showing 1 - 9

Nilusha Hirani, Internal Medicine Medicare: Medicare Enrolled Practice Location: 931 Oakwood Chase Cir, Stone Mountain, GA 30083 Phone: 631-906-9403

Jill Wener, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1551 Juliette Dr, Stone Mountain, GA 30083 Phone: 678-639-2416

Dr. Virginia Davis Floyd, MD, MPH Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1546 Kings Xing, Stone Mountain, GA 30087 Phone: 770-564-3458    Fax: 770-564-3218

Dr. Taneisha Nacoya Benjamin, M.D. Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 1192 Rockbridge Rd, Stone Mountain, GA 30087 Phone: 770-925-2010

Dr. Lisa Carolina Robbins, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1324 Rockbridge Rd, Stone Mountain, GA 30087 Phone: 770-564-1399    Fax: 770-564-1231

Dr. Madhusudan Chandora, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 833 N Hairston Rd, Stone Mountain, GA 30083 Phone: 770-879-5553

Nicholas Kemdi Ihenacho, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5329 Memorial Dr, Suite A, Stone Mountain, GA 30083 Phone: 404-296-7695    Fax: 404-296-7696

Mr. Tadeusz K Wodecki, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2256 Rockbridge Rd, Stone Mountain, GA 30087 Phone: 770-413-1300    Fax: 770-413-0547

Dr. Rose M Taylor, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 715 Village Square Dr, Stone Mountain, GA 30083 Phone: 404-299-8444    Fax: 404-292-8824

News Archive

Radical change to Alzheimer's management

The first disease-modifying drugs are expected to launch from 2013, radically changing the way Alzheimer's disease is treated. With the potential to successfully slow or halt the progression of Alzheimer's, blockbuster revenues are beckoning for such pipeline drugs, claims independent market analyst, Datamonitor.

Morphine plus oxycodone IV combination exhibits improved analgesia, tolerability compared to IV morphine

QRxPharma Limited announced today positive results of its Phase 2 comparative proof-of-concept study to evaluate the efficacy and safety of its IV (intravenous) formulation of morphine plus oxycodone versus IV morphine alone for the treatment of moderate to severe post-operative pain in patients following hip replacement surgery. The main findings demonstrated that QRxPharma's formulation of MoxDuo IV resulted in fewer side effects and offered better pain relief than morphine alone.

UDCA treatment affects C. diff life cycle, reduces inflammatory response in mice

Researchers from North Carolina State University have found that a commonly used drug made from secondary bile acids can affect the life cycle of Clostridioides difficile (C. diff) in vitro and reduce the inflammatory response to C. diff in mice.

Serametrix announces commercial launch of serum test for measuring serum antibodies

Serametrix has announced the commercial launch of a serum test for measuring serum antibodies to the important tumor antigen NY-ESO-1. The test will be offered as a service to drug companies and clinicians for correlative studies, monitoring and potentially predicting patient responses to cancer treatments.

Palo Alto Medical Foundation, El Camino Hospital to explore collaborative partnerships to improve community health

El Camino Hospital and the Palo Alto Medical Foundation today announced that following the return of its delegation to India as part of Mayor Ed Lee's SF Bangalore Sister City Initiative, the organizations will be exploring memoranda of understanding (MOU) with local Indian hospitals, healthcare organizations and technology companies.

Read more Medical News

› Verified 7 days ago